John C. Castle
Impact in
- Virology top 2%
- HIV Research and Treatment
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Immunology 14
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 3
- Immune cells in cancer 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
- Co-authors
- Uğur ŞahinSebastian BoegelÖzlem TüreciMartin LöwerMustafa DikenSebastian KreiterArbel D. TadmorThomas Bukur
- Journals
- OncoImmunology (4 papers)BMC Genomics (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)BMC Medical Genomics (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
John C. Castle
20 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Virology 352
- Immunology 1.5k
- Oncology 1.2k
- Molecular Biology 1.2k
- Cancer Research 212
Countries citing papers authored by John C. Castle
This map shows the geographic impact of John C. Castle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Castle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Castle more than expected).
Fields of papers citing papers by John C. Castle
This network shows the impact of papers produced by John C. Castle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Castle. The network helps show where John C. Castle may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Castle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2022 | 11 | |
| 4 | 2019 | 135 | |
| 5 | 2019 | 89 | |
| 6 | 2019 | 29 | |
| 7 | 2019 | 1 | |
| 8 | 2018 | 73 | |
| 9 | 2018 | 102 | |
| 10 | 2017 | 3 | |
| 11 | 2017 | 24 | |
| 12 | Mutant MHC class II epitopes drive therapeutic immune responses to cancer Hit paper breakdown → | 2015 | 915 |
| 13 | 2014 | 280 | |
| 14 | 2014 | 79 | |
| 15 | 2014 | 31 | |
| 16 | 2013 | 12 | |
| 17 | 2012 | 170 | |
| 18 | 2012 | 51 | |
| 19 | Genome-Scale RNAi Screen for Host Factors Required for HIV Replication Hit paper breakdown → | 2008 | 615 |
| 20 | 2006 | 29 |
About John C. Castle
John C. Castle is a scholar working on Immunology, Oncology, Virology, Sensory Systems and Cancer Research, having authored 21 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), vaccines and immunoinformatics approaches (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (4 papers), RNA Interference and Gene Delivery (3 papers), T-cell and B-cell Immunology (3 papers), CAR-T cell therapy research (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Virology (352 citations), Immunology (1.5k citations), Oncology (1.2k citations), Molecular Biology (1.2k citations) and Cancer Research (212 citations). John C. Castle has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Uğur Şahin, Sebastian Boegel, Özlem Türeci, Martin Löwer, Mustafa Diken, Sebastian Kreiter, Arbel D. Tadmor, Thomas Bukur, Jan Diekmann and Mathias Vormehr. Their work appears in journals such as OncoImmunology, BMC Genomics, Journal for ImmunoTherapy of Cancer, BMC Medical Genomics and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.